Skip to main content
Livermore
Livermore
ZHEN

Sarepta Therapeutics, Inc.

SRPT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000873303

No open-market purchases or sales by Sarepta Therapeutics, Inc. insiders were filed in the last 90 days; 323 institutions reported holding it in 13F filings for Q2 2026, worth $1.93B in total; no superinvestor holds it.

Holders of 5% or more of SRPT

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Sarepta Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of SRPT
HolderLatest formStakeChangeFirst filedLatest filingFiling
BlackRock, Inc.13G/A15.80%16.6M shares+3.20 ppfrom 12.60%Jan 21, 20262 filingsJul 30, 2026SEC
State Street Corp13G8.40%8.92M shares+3.00 ppfrom 5.40%Nov 10, 20252 filingsAug 7, 2026SEC
Vanguard Portfolio Management LLC13G/A8.05%8.50M shares+1.62 ppfrom 6.43%Apr 29, 20262 filingsJul 31, 2026SEC
Vanguard Capital Management LLC13G5.11%5.37M sharesNewApr 30, 20261 filingApr 30, 2026SEC
AQR Capital Management LLC13G/A5.05%5.33M shares−2.68 ppfrom 7.73%Feb 13, 20262 filingsAug 13, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

21 Schedule 13D and 13G filings on Sarepta Therapeutics, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on SRPT
Filed (ET)FilerFormStakeChangeEvent dateFiling
Aug 13, 20261:39 PM ETAQR Capital Management LLCand 1 other13G/A5.05%5.33M shares−2.68 ppfrom 7.73%Jun 30, 2026SEC
Aug 7, 202610:54 AM ETState Street Corpand 1 other13G8.40%8.92M shares+3.00 ppfrom 5.40%Jun 30, 2026SEC
Jul 31, 202611:40 AM ETVanguard Portfolio Management LLC13G/A8.05%8.50M shares+1.62 ppfrom 6.43%Jun 30, 2026SEC
Jul 30, 202611:18 AM ETBlackRock, Inc.13G/A15.80%16.6M shares+3.20 ppfrom 12.60%Jun 30, 2026SEC
Apr 30, 20261:09 PM ETVanguard Capital Management LLC13G5.11%5.37M sharesNewMar 31, 2026SEC
Apr 29, 20263:13 PM ETVanguard Portfolio Management LLC13G6.43%6.75M sharesNewMar 31, 2026SEC
Mar 27, 20261:00 PM ETVanguard Group Inc13G/A0.00%0 shares−10.89 ppfrom 10.89%Below 5%Mar 13, 2026SEC
Feb 13, 202611:52 AM ETAQR Capital Management LLCand 1 other13G7.73%8.10M sharesNewDec 31, 2025SEC
Jan 21, 202612:30 PM ETBlackRock, Inc.13G/A12.60%13.2M shares–Dec 31, 2025SEC
Nov 14, 20254:08 PM ETD. E. Shaw & Co, L.P.and 1 other13G/A1.90%2.01M shares−3.20 ppfrom 5.10%Below 5%Sep 30, 2025SEC
Nov 10, 20258:54 AM ETState Street Corp13G5.40%5.30M sharesNewSep 30, 2025SEC
Sep 8, 202511:06 AM ETVanguard Group Inc13G/A10.89%10.6M shares–Aug 29, 2025SEC
Aug 13, 202512:49 PM ETCapital International Investors13G/A0.50%524.1K shares−8.80 ppfrom 9.30%Below 5%Jun 30, 2025SEC
Jul 25, 20258:14 PM ETD. E. Shaw & Co, L.P.and 1 other13G/A5.10%5.06M shares0.00 ppfrom 5.10%Jul 18, 2025SEC
Jul 25, 20254:08 PM ETD. E. Shaw & Co, L.P.and 1 other13G5.10%5.06M sharesNewJul 18, 2025SEC
Feb 14, 20251:32 PM ETCapital International Investors13G/A9.30%8.90M shares–Dec 31, 2024SEC
Feb 16, 2021Sands Capital Management, LLC13GOld format–New–SEC
Feb 10, 2021Capital Research Global Investors13G/AOld format–––SEC
Feb 10, 2021Capital Research Global Investors13GOld format–New–SEC
Feb 10, 2021Vanguard Group Inc13G/AOld format–––SEC
Feb 8, 2021FMR LLC13G/AOld format–––SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Sarepta Therapeutics, Inc. shares.

No Form 144 notices for Sarepta Therapeutics, Inc. are on file.